Preferred language definition

Preferred language means the employee's language of choice.
Sample 1Sample 2Sample 3
Preferred language means a parent’s or guardian’s native language or any other language with which the parent or guardian requests interpretation services. “Preferred language” does not include artificial or constructed languages, including, but not limited to, Klingon, Dothraki, Elvish, or Esperanto.
Sample 1Sample 2
Preferred language means a parent's or guardian's native language or any other language with which both parents or guardians are fluent and have agreed upon. Preferred language does not include artificial or constructed languages, including, but not limited to, Klingon, Dothraki, Elvish, or Esperanto.
Sample 1

Examples of Preferred language in a sentence

  • City:State:Zip:City:State:Zip: County:County: Contact Information: Complete at least oneYour Email Address (required):Primary Phone: ( )Type:Home CellVoice Msg.WorkSecondary Phone: ( )Type:Home CellVoice Msg.Work Preferred Contact Method: Phone Email Mail Preferred language spoken in the home: There are other programs that can benefit you and your family...

  • Whether the [ Preferred language ] field is filled out on the contact page.

  • Same as company address Preferred language Company nameGermanEnglish Street, no.

  • Same as company address Preferred language German English Company nameStreet, no.Postal codeCity PO Box PO Box postal code, City CountryPhoneFax E-mail Contact person for billing address First nameWebsite Ms Mr SurnameVAT no.

  • Voltage for equipment: 220V / 60Hz » Preferred language for manuals and software: Spanish ¤ FOR IAEA: » Donation Letter required.

  • Basic DetailsTitle (Mr, Mrs, Ms, Miss, Dr) Surname First Name(s) Full Address (If different from Section A) Country Post Code Contact Number Home: Work Mobile Number E-mail address Preferred language of communication Welsh English National Insurance Number Date of Birth 2).

  • Preferred language for questions about unclear instructions (N=94).

  • This may be found on overseas medical examination records, and sometimes on visas or other official U.S. documentation.MM/DD/YYYYLanguage needs: Preferred language, language used for interpretationThis may be found on overseas medical examination records.

  • Preferred language on answers to questions posed in Swedish (N=96).

  • Country of residence: Preferred language for official correspondence: English French CPA students and candidates residing in Canada must be eligible to study in Canada.


More Definitions of Preferred language

Preferred language means the language chosen by the applicant or individual, or, when appropriate, the individual’s parent, legal guardian or conservator, or authorized representative.
Sample 1
Preferred language. Marital Status: Signature: Date: In case of medical emergency, please notify: Scan/File Original in the Medical Record For Treatment: We may use health information about you to provide you with medical treatment or services. We may disclose health information about you to doctors, nurses, technicians, health care students, or other personnel who are involved in taking care of you. For example, a doctor treating you for a broken leg may need to know if you have diabetes because diabetes may slow the healing process. In addition, the doctor may need to tell the dietitian if you have diabetes so that we can arrange for appropriate meals. Different departments also may share health information about you in
Sample 1
Preferred language means the self-identified language that the client prefers to use in a service or clinical encounter.99 The preferred language need not be the client’s native or primary language if the client prefers to use English.
Sample 1
Preferred language. Religion: Alleged Perpetrator: Relationship to Alleged Perpetrator: Children: Accommodation: Previous Incidents: Help Sought:
Sample 1
Preferred language. Marital Status: Signature: Date: In case of medical emergency, please notify:
Sample 1

Related to Preferred language

  • Primary language means the dominant language used by a person for communication.

  • Native language means, if used in reference to an individual of limited English proficiency, the following:

  • Speech-language pathology means the care and services provided by a licensed speech-language pathologist as set forth in the member state's statutes and rules.

  • Speech-language pathologist means an individual who is licensed by a state to practice speech-language pathology.

  • plain language means language that can be understood by a reasonable person, applying a reasonable effort;

  • English Language French Language:

  • English language learner means limited English proficient pupils who speak a language other than English as their primary language and have difficulty speaking, reading, writing, or understanding English as reported to the center.

  • Speech or language impairment means a communication disorder, such as stuttering, impaired articulation, a language impairment, or a voice impairment, that adversely affects a child’s educational performance.

  • Unproven/ Experimental treatment means the treatment including drug experimental therapy which is not based on established medical practice in India.

  • Common Language Location Identifier (CLLI) codes provide a unique 11-character representation of a network interconnection point. The first 8 characters identify the city, state and building location, while the last 3 characters identify the network component.

  • Clinical Study means a Xxxxx 0 Xxxxx, Xxxxx 2 Study, Phase 3 Study, Post-Marketing Study, Supplemental Study or other study (including a non-interventional study) in humans to obtain information regarding the product, including information relating to the safety, tolerability, pharmacological activity, pharmacokinetics, dose ranging or efficacy of the product.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Pivotal Trial means a clinical study in humans of the efficacy and safety of a Licensed Product that is prospectively designed to demonstrate with statistical significance that such product is effective and safe for use in a particular indication in a manner sufficient to file for Marketing Approval of such product and would satisfy the requirements of 21 CFR 312.21(c), or a similar clinical study prescribed by the Regulatory Authorities in a country other than the United States.

  • Common Language Location Identifier (CLLI) means the codes that provide a unique eleven (11) character representation of a network interconnection point. The first eight (8) characters identify the city, state and building location, while the last three (3) characters identify the network component.

  • Domestic content procurement preference ’ means all iron and steel used in the project are produced in the United States; the manufactured products used in the project are produced in the United States; or the construction materials used in the project are produced in the United States.

  • Pivotal Study means (a) a Phase 3 Study that is intended by Celgene to be submitted (together with any other registration trials that are prospectively planned when such Phase 3 Study is initiated) for Regulatory Approval in the U.S. or the EU, or (b) any other clinical study that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions, and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which clinical study is a registration trial intended to be sufficient for filing an application for a Regulatory Approval for the Licensed Product in the U.S. or another country or some or all of an extra-national territory, solely as evidenced by the acceptance for filing for a Regulatory Approval for such product after completion of such study.

  • Pivotal Clinical Trial means a Phase 3 Clinical Trial, or a Phase 2b Clinical Trial for which the applicable Regulatory Authority has determined that the data generated in such Phase 2b Clinical Trial would be sufficient, depending on its outcome, to support the Regulatory Approval for the applicable Licensed Product.

  • Scoping meeting means a meeting between representatives of the applicant and the EDU conducted for but not limited to the following purposes:

  • Protocol means, in respect of any category of object and associated rights to which this Convention applies, the Protocol in respect of that category of object and associated rights;

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.